Palatin Technologies, Inc. (PTN)
14.31
-0.93
(-6.10%)
USD |
NYAM |
May 19, 15:49
Palatin Technologies EPS Diluted (Quarterly) : -0.3663 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.433M |
| Revenue (Quarterly) | 3.921M |
| Total Expenses (Quarterly) | 5.354M |
| Enterprise Value | 4.294M |
| Gross Profit Margin (Quarterly) | 99.57% |
| Profit Margin (Quarterly) | -36.55% |
| Earnings Yield | -9.55% |
| Normalized Earnings Yield | -9.553 |